A full course of radiation therapy in the United States typically costs between $8,000 and $50,000 or more before insurance, depending on the type of cancer, the radiation technology used, and how many treatment sessions you need. Most people with insurance don’t pay that full amount, but out-of-pocket costs can still run into thousands of dollars even with good coverage.
What Drives the Total Price
Radiation therapy isn’t a single bill. It’s a series of charges that stack up over weeks or months: an initial consultation with a radiation oncologist, imaging and simulation sessions to map out the treatment area, a custom treatment plan, and then the delivery sessions themselves, which can range from a single session to 30 or more. Each of these steps generates its own charge.
The simulation phase alone involves defining the exact anatomy being targeted, acquiring detailed imaging data, and sometimes using contrast materials or respiratory motion tracking to account for breathing movement. For more advanced techniques, these planning steps are bundled into a single billing code, but for standard treatments, simulation complexity (and cost) scales with the number of treatment areas involved. On top of that, you may need custom immobilization devices, essentially molds or masks that hold you in the exact same position for every session.
The biggest cost driver is the number of delivery sessions. A conventional breast cancer treatment course using six weeks of daily radiation runs over $13,000 in Medicare reimbursement terms, while a shorter three-to-four-week regimen for the same cancer drops to roughly $8,000. Fewer sessions mean lower costs across the board.
Cost Differences by Radiation Type
Not all radiation is priced equally. Standard photon-based treatments like intensity-modulated radiation therapy (IMRT) are the most common and generally the least expensive option for external beam radiation. Proton beam therapy, which uses charged particles to deliver radiation more precisely, costs significantly more. A full course of proton therapy runs about 1.5 times the cost of a comparable IMRT course. On a per-session basis, the gap is even wider: a single proton therapy fraction costs roughly 2.8 times more than a single IMRT fraction. The overall cost gap narrows somewhat because proton therapy patients sometimes need fewer supportive care services during treatment, but it remains a meaningfully more expensive option.
Stereotactic treatments, which deliver very high doses in just one to five sessions, have their own pricing structure. Stereotactic radiosurgery (SRS), a single-session approach often used for brain tumors, tends to be the least expensive of these specialized options. A three-session stereotactic body radiation therapy (SBRT) course costs roughly 17% to 27% more than a single SRS session, depending on the planning technique. Extending SBRT to five sessions adds another 32% to 34% on top of the three-session price. The cost differences come mainly from the delivery sessions themselves rather than the planning process, which is comparably intensive regardless of how many sessions you receive.
What Insurance Typically Covers
Medicare Part B covers radiation therapy for outpatients and patients treated in freestanding clinics. After meeting the annual Part B deductible, you pay 20% of the Medicare-approved amount for each service. That 20% coinsurance applies to every component: planning, simulation, and each delivery session.
Private insurance plans generally follow a similar structure. You pay a deductible first, then split the remaining costs with your insurer at a coinsurance rate that’s typically 10% to 20%. The critical number to know is your plan’s annual out-of-pocket maximum, which caps what you’ll spend in a given year. For commercially insured patients, that cap averages around $4,064. For Medicare Advantage plans, it averages about $4,661.
Here’s the key finding: research examining actual patient costs found that 100% of commercially insured radiation therapy patients hit their annual out-of-pocket maximum during treatment. Among Medicare Advantage patients, about 55% reached theirs. In practical terms, this means if you have commercial insurance and need a full course of radiation, you should plan on paying up to your plan’s out-of-pocket maximum for the year, because the total billed amount will almost certainly exceed it. Once you hit that cap, your insurer covers the rest completely.
Common Cost Ranges by Cancer Type
Breast cancer radiation offers a useful benchmark because it’s one of the most frequently treated cancers with radiation and because shorter treatment courses have become standard. A conventional six-week course costs over $13,000 at Medicare rates. Hypofractionated regimens, which deliver slightly larger doses over three to four weeks, cost around $8,000. Many patients are now candidates for these shorter courses with equivalent outcomes, which cuts costs substantially.
Prostate cancer radiation tends to fall on the higher end because treatment courses are often longer (up to eight or nine weeks for conventional fractionation) or because patients opt for proton therapy. SBRT for early-stage prostate cancer, delivered in just five sessions, has become increasingly common and can bring total costs down compared to a longer IMRT course, though each individual session is more expensive.
Lung cancer patients receiving SBRT for small, early-stage tumors typically complete treatment in three to five sessions. Brain metastases treated with SRS may require only a single session. These shorter courses have lower total costs than conventional multi-week treatments, but the per-session charges are higher due to the precision and planning involved.
Costs You Might Not Expect
The sticker price for radiation delivery is only part of the picture. Several additional expenses can catch patients off guard:
- Treatment planning fees: The radiation oncologist’s work integrating your medical condition, determining the treatment modality, setting the total dose and fractionation schedule, and planning any field changes generates professional charges separate from the facility fees.
- Imaging during treatment: Many modern techniques require verification imaging at each session to confirm you’re positioned correctly. These image-guidance charges add up over a multi-week course.
- Transportation and time off work: Radiation therapy typically requires daily visits, Monday through Friday, for several weeks. Travel costs and lost wages can rival or exceed the medical bills themselves, especially for patients who live far from a treatment center.
- Supportive medications: Skin creams, anti-nausea drugs, and pain management during treatment are billed separately and may fall under your pharmacy benefit rather than your medical benefit, meaning a different deductible and cost-sharing structure.
Financial Help for Radiation Patients
If the costs feel unmanageable, several options exist. Most radiation oncology practices have financial counselors who can walk you through your expected costs before treatment begins and set up payment plans. Hospitals are required to offer financial assistance programs for patients who qualify based on income, and many will discount or write off balances for uninsured or underinsured patients.
Nonprofit organizations like CancerCare offer limited financial grants that can help cover radiation-related costs. Their co-payment assistance foundation primarily covers chemotherapy and targeted therapy medications, but CancerCare’s broader programs may provide grants for other treatment expenses. Individuals or families earning up to five times the federal poverty level may qualify. You can reach their co-payment specialists at 866-552-6729.
Other organizations worth contacting include the Patient Advocate Foundation, which runs co-pay relief programs for specific cancer diagnoses, and the HealthWell Foundation. Many pharmaceutical and device manufacturers also maintain patient assistance programs, though these are more commonly tied to drug costs than radiation. State Medicaid programs cover radiation therapy for eligible patients with no or minimal cost-sharing, and some states have expanded eligibility specifically for cancer patients through Medicaid breast and cervical cancer treatment programs.